Page 3 - Berndr Seizinger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Berndr seizinger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Berndr Seizinger Today - Breaking & Trending Today

Aptose Biosciences (NASDAQ:APTO) Stock Rating Upgraded by StockNews.com

Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Monday. Several other equities analysts also recently issued reports on APTO. HC Wainwright boosted their price target on shares of Aptose Biosciences from $12.00 to […] ....

Berndr Seizinger , Aptose Biosciences , Piper Sandler , Millennium Management , Aptose Biosciences Inc , Cetera Advisors , Cantor Fitzgerald , Royal Bank , Sequoia Financial Advisors , Sigma Planning Corp , Renaissance Technologies , Securities Exchange Commission , Get Free Report , Director Bernd , Exchange Commission , Financial Advisors , Planning Corp , Biosciences Inc , Aptose Biosciences Daily , Nasdaq Apto , Stocknews Com ,

Aptose Biosciences (NASDAQ:APTO) PT Lowered to $18.00 at Royal Bank of Canada

Aptose Biosciences (NASDAQ:APTO) PT Lowered to $18.00 at Royal Bank of Canada
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Piper Sandler , Berndr Seizinger , Aptose Biosciences , Renaissance Technologies , Aptose Biosciences Inc , Cetera Advisors , Cantor Fitzgerald , Securities Exchange Commission , Annandale Capital , Royal Bank , Aptose Biosciences Company Profile , Sequoia Financial Advisors , Millennium Management , Free Report , Moderate Buy , Director Bernd , Exchange Commission , Financial Advisors , Get Free Report , Biosciences Inc , Aptose Biosciences Daily ,

Short Interest in Aptose Biosciences Inc. (NASDAQ:APTO) Increases By 37.8%

Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 41,900 shares, a growth of 37.8% from the October 15th total of 30,400 shares. Currently, 1.7% of the company’s shares are sold […] ....

Aptose Biosciences , Berndr Seizinger , Aptose Biosciences Company Profile , Cantor Fitzgerald , Renaissance Technologies , Sigma Planning Corp , Aptose Biosciences Inc , Royal Bank , Millennium Management , Annandale Capital , Get Free Report , Director Bernd , Planning Corp , Biosciences Inc , Aptose Biosciences Daily , Nasdaq Apto ,

Aptose Biosciences (NASDAQ:APTO) Given New $18.00 Price Target at Royal Bank of Canada

Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) had its price objective lowered by equities research analysts at Royal Bank of Canada from $23.00 to $18.00 in a report released on Friday, Benzinga reports. The brokerage currently has an “outperform” rating on the biotechnology company’s stock. Several other brokerages have also recently issued reports on […] ....

Aptose Biosciences , Piper Sandler , Berndr Seizinger , Sigma Planning Corp , Aptose Biosciences Inc , Renaissance Technologies , Royal Bank , Annandale Capital , Cantor Fitzgerald , Millennium Management , Get Free Report , Director Bernd , Planning Corp , Biosciences Inc , Aptose Biosciences Daily , Nasdaq Apto , Lower Price Target , Royal Bank Of Canada ,

Aptose Biosciences Inc. (NASDAQ:APTO) Given Consensus Recommendation of "Buy" by Brokerages

Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) has earned an average rating of “Buy” from the six ratings firms that are presently covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have issued a report on the […] ....

Piper Sandler , Berndr Seizinger , Aptose Biosciences , Aptose Biosciences Inc , Sequoia Financial Advisors , Cetera Advisors , Cantor Fitzgerald , Renaissance Technologies , Annandale Capital , Millennium Management , Get Free Report , Marketbeat Ratings , Director Bernd , Financial Advisors , Get Free , Biosciences Inc , Aptose Biosciences Daily , Nasdaq Apto ,